PRECEDE Consortium Announces Konica Minolta Precision Medicine as its Precision Health Partner to Advance its Mission to Increase Survival Rates for Patients with Pancreatic Cancer

ALISO VIEJO, Calif.: ALISO VIEJO, Calif., Aug. 17, 2021 /PRNewswire/ -- The PRECEDE Consortium (PRECEDE) and Konica Minolta Precision Medicine, Inc. (KMPM) announced today that KMPM and its subsidiaries, Ambry Genetics and Invicro, have joined as partners to bring a novel integrated diagnostic approach to support PRECEDE's mission for increasing...

Click to view original post